Multicenter, Prospective, Randomised and Comparative Study of AA Therapy and Early Administrating Enzalutamide in Participants With CRPC Previously Treated With CAB Therapy Using Bicalutamide.
Phase of Trial: Phase II
Latest Information Update: 21 Dec 2016
At a glance
- Drugs Enzalutamide (Primary) ; Flutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 16 Dec 2016 Planned primary completion date changed from 1 Mar 2018 to 1 Sep 2018.
- 28 Jan 2015 New trial record